Impact of the 2022 ATS/ERS update criteria on the bronchodilator responsiveness test result.

Pulmonology

Pulmonology Department & Sleep and NIV Unit, São João University Hospital, Porto, Portugal; Center for Health Technology and Services Research - CINTESIS, Porto, Portugal; Faculty of Medicine of University of Porto, Porto, Portugal; Escola Superior de Saúde do Politécnico do Porto - ESS P.PORTO, Porto, Portugal.

Published: July 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pulmoe.2024.06.003DOI Listing

Publication Analysis

Top Keywords

impact 2022
4
2022 ats/ers
4
ats/ers update
4
update criteria
4
criteria bronchodilator
4
bronchodilator responsiveness
4
responsiveness test
4
test result
4
impact
1
ats/ers
1

Similar Publications

This study aimed to explore the awareness, willingness, and engagement with pre-exposure prophylaxis (PrEP) among high-risk Chinese men who have sex with men (MSM) and to investigate the factors influencing its use. A cross-sectional survey of 1800 HIV-negative MSM was conducted in Chengdu, Suzhou, and Wuhan between June 2022 and February 2023 through in-person and online recruitment methods. Univariate and multivariate logistic regression analyses were used to identify predictors of PrEP use.

View Article and Find Full Text PDF

Cancers of the brain and central nervous system: global patterns and trends in incidence.

J Neurooncol

January 2025

Cancer Surveillance Branch, International Agency for Research On Cancer (IARC), 25 Avenue Tony Garnier, CS 90627, 69366 LYON CEDEX 07, Lyon, France.

Background: Global comparisons of the burden and impact of cancers of the brain and central nervous system (CNS) are critical for developing effective control strategies and generating etiological hypotheses to drive future research.

Methods: National incidence estimates were obtained from GLOBOCAN 2022, and recorded incidence data from the Cancer in Five Continents series, both developed and compiled by the International Agency for Research on Cancer. We examined the estimated age-standardized incidence rates in 185 countries, as well as time trends in recorded incidence in 35 countries, quantifying the direction and change in the magnitude of the rates using the estimated average percentage change (EAPC).

View Article and Find Full Text PDF

Background: Primary hyperparathyroidism (PHPT) due to a parathyroid adenoma stands as one of the most prevalent endocrinological disorders, with focused parathyroidectomy being the established therapeutic strategy.

Aim: This study aims to investigate whether the volume of the pathological gland influences perioperative outcomes and postoperative morbidity.

Methods: A retrospective analysis was conducted on data from 141 patients who underwent focused parathyroidectomy for PHPT at the University Hospital of Basel between 2007 and 2022.

View Article and Find Full Text PDF

Purpose: This study aimed to evaluate the long-term impact of mild COVID-19 infection and COVID-19 vaccination on ovarian function in patients undergoing assisted reproductive technology (ART). Specifically, we assessed ovarian outcomes between 9 and 18 months post-infection and investigated the effects of COVID-19 vaccines (inactivated virus and adenovirus) on reproductive parameters.

Methods: The study included two objectives: (a) examining ovarian function in post-COVID-19 patients (9-18 months post-infection) compared to a control group and (b) comparing reproductive outcomes in vaccinated versus unvaccinated patients.

View Article and Find Full Text PDF

Introduction: Type 1 diabetes (T1D) requires constant self-management and substantially impacts daily life. We surveyed the experiences/burdens of people with T1D (PWD) and their caregivers.

Methods: An online survey of PWD/caregivers (aged ≥ 18 years) living in five European countries was conducted from July to August 2021.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!